LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $203,000 | -45.1% | 1,612 | -28.1% | 0.00% | -50.0% |
| Q1 2018 | $370,000 | +28.9% | 2,242 | +7.1% | 0.00% | 0.0% |
| Q4 2017 | $287,000 | -20.1% | 2,093 | -20.6% | 0.00% | 0.0% |
| Q3 2017 | $359,000 | +6.2% | 2,637 | -5.1% | 0.00% | 0.0% |
| Q2 2017 | $338,000 | +19.9% | 2,780 | +4.5% | 0.00% | 0.0% |
| Q1 2017 | $282,000 | -48.3% | 2,660 | -50.4% | 0.00% | -33.3% |
| Q4 2016 | $545,000 | +1.1% | 5,366 | +1.5% | 0.00% | 0.0% |
| Q3 2016 | $539,000 | -16.8% | 5,289 | -2.8% | 0.00% | -25.0% |
| Q2 2016 | $648,000 | +14.3% | 5,441 | +2.6% | 0.00% | 0.0% |
| Q1 2016 | $567,000 | +70.8% | 5,305 | +72.5% | 0.00% | +100.0% |
| Q4 2015 | $332,000 | -75.4% | 3,076 | -84.7% | 0.00% | -60.0% |
| Q1 2014 | $1,348,000 | – | 20,057 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |